The recent gift rounds the Foundation’s support of CHOC’s neonatal services to $7 million in the past 12 months.
CHOC performs first in-human gene therapy dosing for MPS I
CHOC clinicians recently administered the first ever in-human dosing of gene therapy for Hurler Syndrome, a rare lysosomal storage disease.
Journey to a rare diagnosis: Colten’s story
A CHOC PICU nurse tells the story of her son, Colten, who received a rare Alström Syndrome diagnosis with the help of specialists at CHOC.
How CHOC otolaryngologists are changing tonsillectomy recovery
Two CHOC otolaryngologists are championing intracapsular tonsillectomies to reduce bleeding and hospital readmission rates.
The moving way CHOC supports families of pediatric organ donors
CHOC’s Walk of Honor honors families’ selfless and courageous decision to donate their child’s organs upon their death.
Leprosy antibiotic is safe treatment for M. abscessus infections, CHOC infectious disease team finds
An oral antibiotic used to treat leprosy is safe and well-tolerated in children with challenging-to-treat mycobacterium abscessus infections.
